INOGEN, INC. (INGN) Operating Margin
- Operating margin · 12 months: Value -10.16%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -10.16% | Operating income / revenue. Period ending 2026-06-30. $-30.85M ÷ $303.59M × 100 ≈ -10.16% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -30.85M USD | Operating Income (Loss) |
| Revenue | 303.59M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 167.41M USD | Cost of Goods and Services Sold |
| Research and development | 21.12M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-30.85M | $303.59M | $167.41M | $21.12M | (m) | -10.16% |
| 2026-03-31 | $-31.89M | $299.24M | $165.93M | $20.46M | (m) | -10.66% |
| 2025-12-31 | $-30.21M | $295.30M | $163.84M | $19.40M | (m) | -10.23% |
| 2025-09-30 | $-32.29M | $293.04M | $159.98M | $19.98M | (m) | -11.02% |
| 2025-06-30 | $-32.96M | $288.88M | $156.64M | $18.66M | (m) | -11.41% |
| 2025-03-31 | $-33.90M | $284.13M | $151.49M | $19.07M | (m) | -11.93% |
| 2024-12-31 | $-42.52M | $278.76M | $148.66M | $21.61M | (m) | -15.25% |
| 2024-09-30 | $-60.11M | $271.85M | $153.09M | $22.43M | (m) | -22.11% |
| 2024-06-30 | $-99.04M | $264.90M | $156.21M | $23.40M | (m) | -37.39% |
| 2024-03-31 | $-103.75M | $258.81M | $159.92M | $22.07M | (m) | -40.08% |
| 2023-12-31 | $-109.39M | $251.61M | $158.64M | $20.84M | (m) | -43.47% |
| 2023-09-30 | $-138.89M | $265.39M | $170.45M | $20.06M | (m) | -52.34% |
| 2023-06-30 | $-102.46M | $288.09M | $183.64M | $20.15M | (m) | -35.57% |
| 2023-03-31 | $-93.57M | $309.03M | $192.27M | $21.92M | (m) | -30.28% |
| 2022-12-31 | $-85.24M | $320.55M | $197.81M | $21.94M | (m) | -26.59% |
| 2022-09-30 | $-33.43M | $310.74M | $178.24M | $20.69M | (m) | -10.76% |
| 2022-06-30 | $-16.76M | $301.04M | $162.78M | $19.87M | (m) | -5.57% |
| 2022-03-31 | $-2.21M | $302.05M | $158.69M | $17.93M | (m) | -0.73% |
| 2021-12-31 | $9.24M | $311.73M | $161.82M | $16.58M | (m) | 2.96% |
| 2021-09-30 | $10.39M | $312.99M | $165.49M | $15.57M | (m) | 3.32% |
| 2021-06-30 | $2.04M | $298.82M | $162.76M | $15.32M | (m) | 0.68% |
| 2021-03-31 | $-11.98M | $274.13M | $152.28M | $14.49M | (m) | -4.37% |
| 2020-12-31 | $-12.03M | $280.19M | $156.76M | $14.08M | (m) | -4.29% |
| 2020-09-30 | $-11.82M | $289.03M | $162.82M | $14.03M | (m) | -4.09% |
| 2020-06-30 | $-1.74M | $308.62M | $169.88M | $13.16M | (m) | -0.57% |
| 2020-03-31 | $12.75M | $338.87M | $181.03M | $11.34M | (m) | 3.76% |
| 2019-12-31 | $19.79M | $340.55M | $175.97M | $9.40M | (m) | 5.81% |
| 2019-09-30 | $29.89M | $347.81M | $173.33M | $7.51M | (m) | 8.59% |
| 2019-06-30 | $32.17M | $351.13M | $171.37M | $6.97M | (m) | 9.16% |
| 2019-03-31 | $34.05M | $347.25M | $169.11M | $7.28M | (m) | 9.81% |
| 2018-12-31 | $37.89M | $336.01M | $163.99M | $7.03M | (m) | 11.28% |
| 2018-09-30 | $38.31M | (m) | $153.58M | $6.66M | (m) | (m) |
| 2018-06-30 | $36.24M | (m) | $142.17M | $5.93M | (m) | (m) |
| 2018-03-31 | $30.72M | (m) | $125.20M | $5.42M | (m) | (m) |
| 2017-12-31 | $27.59M | (m) | $110.16M | $5.31M | (m) | (m) |
| 2017-09-30 | $28.57M | (m) | $102.64M | $5.16M | (m) | (m) |
| 2017-06-30 | $25.64M | (m) | $95.51M | $5.13M | (m) | (m) |
| 2017-03-31 | $25.16M | (m) | $90.56M | $5.25M | (m) | (m) |
| 2016-12-31 | $22.86M | (m) | $85.15M | $5.11M | (m) | (m) |
| 2016-09-30 | $20.17M | (m) | $78.88M | $5.12M | (m) | (m) |
| 2016-06-30 | $18.48M | (m) | $70.65M | $4.89M | (m) | (m) |
| 2016-03-31 | $15.81M | (m) | $65.47M | $4.49M | (m) | (m) |
| 2015-12-31 | $15.05M | (m) | $61.55M | $4.18M | (m) | (m) |
| 2015-09-30 | $13.01M | (m) | $56.83M | $3.62M | (m) | (m) |
| 2015-06-30 | $12.86M | (m) | $50.92M | $3.30M | (m) | (m) |
| 2015-03-31 | $11.48M | (m) | $43.74M | $3.21M | (m) | (m) |
| 2014-12-31 | $10.51M | (m) | $38.69M | $2.98M | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $4.46M | (m) | $24.31M | $2.40M | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $829.00K | (m) | $17.38M | $2.26M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |